
Revitalizing Primary Care Internal Medicine
Sep 14, 2026 - 36:44
Radio and PodcastLive Radio & Podcasts
Dr. Centor discusses the comparative risk for severe gastrointestinal adverse events associated with dulaglutide, semaglutide, and tirzepatide with Dr. Wajd Alkabbani.